Non-peptide fibrinogen receptor antagonists. 1. D... [J Med Chem. 1992] - PubMed

Related citations

Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. [J Med Chem. 1994]
Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp.
Egbertson MS, Chang CT, Duggan ME, Gould RJ, Halczenko W, Hartman GD, Laswell WL, Lynch JJ Jr, Lynch RJ, Manno PD. J Med Chem. 1994 Aug 5; 37(16):2537-51.
Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata. [J Biol Chem. 1994]
Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
Karczewski J, Endris R, Connolly TM. J Biol Chem. 1994 Mar 4; 269(9):6702-8.
The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin. [Proc Soc Exp Biol Med. 1991]
The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin.
Gartner TK, Taylor DB. Proc Soc Exp Biol Med. 1991 Oct; 198(1):649-55.
Review Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications. [Curr Med Chem. 2004]
Review Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
Andronati SA, Karaseva TL, Krysko AA. Curr Med Chem. 2004 May; 11(9):1183-211.
Review Development of GPIIb/IIIa antagonists as antithrombotic drugs. [Trends Pharmacol Sci. 1992]
Review Development of GPIIb/IIIa antagonists as antithrombotic drugs.
Nichols AJ, Ruffolo RR Jr, Huffman WF, Poste G, Samanen J. Trends Pharmacol Sci. 1992 Nov; 13(11):413-7.

See reviews... See all...

Cited by 4 PubMed Central articles

Integrin targeted therapeutics. [Theranostics. 2011]
Integrin targeted therapeutics.
Millard M, Odde S, Neamati N. Theranostics. 2011 Feb 17; 1:154-88. Epub 2011 Feb 17.
Review Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. [Am J Pathol. 2009]
Review Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.
Nishimura SL. Am J Pathol. 2009 Oct; 175(4):1362-70. Epub 2009 Sep 3.
Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller. [Blood. 2009]
Species differences in small molecule binding to alpha IIb beta 3 are the result of sequence differences in 2 loops of the alpha IIb beta propeller.
Basani RB, Zhu H, Thornton MA, Soto CS, Degrado WF, Kowalska MA, Bennett JS, Poncz M. Blood. 2009 Jan 22; 113(4):902-10. Epub 2008 Nov 5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite ...
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.
J Med Chem. 1992 Nov 27 ;35(24):4640-2.

PubMed
3D database searching in drug design.
3D database searching in drug design.
J Med Chem. 1992 Jun 12 ;35(12):2145-54.

PubMed
A prospective longitudinal study of depression, cognitive decline, and physical ...
A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease.
J Neurol Neurosurg Psychiatry. 1992 May ;55(5):377-82.

PubMed
Bran and irritable bowel syndrome: time for reappraisal.
Bran and irritable bowel syndrome: time for reappraisal.
Lancet. 1994 Jul 2 ;344(8914):39-40.

PubMed
Methionine-enkephalin deficiency in brains of patients with Parkinson's disease.
Methionine-enkephalin deficiency in brains of patients with Parkinson's disease.
Lancet. 1981 Jun 20 ;1(8234):1367-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.

Source

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Chemical Information

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information